Skip to main content

Our development and production network spans across the globe

Our services are available to partners worldwide. Our locations on three continents offer state-of-the-art manufacturing facilities, as well as the expert knowledge to help our partners make the most of them. We constantly invest in both capacity and capability.

Biberach, Germany

Biberach is where our Boehringer Ingelheim BioXcellence™ story began, and is still the launch site for almost all of our customer commercial products.

Clinical and commercial supply

Manufacture and launch of therapeutic proteins and antibodies

Aseptic Filling in vials for liquids and lyophilizates

Core technology: fed-batch large-scale manufacturing in 15,000 L bioreactors, N-1 perfusion processes in 2,000 L bioreactors

Vienna, Austria

The only site in our network offering both microbial and mammalian technology, Vienna’s new Large Scale Cell Culture facility has a flexible total mammalian capacity of 135,000 L. Its leading-edge efficiency is driven by smart technologies and artificial intelligence.

Clinical and commercial supply

Cell line and process development of proteins obtained from E. coli or yeast

Mammalian technology: 15,000 L capacity

Microbial technology: 30 – 6,000 L capacity

Specialists in microbial fermentation, manufacturing e.g., recombinant proteins, recombinant vaccines, antibody-mimetics and plasmid DNA

Fremont, CA, US

Our mammalian technology plant in California is ideal for large-scale parallel projects, with two flexible cell culture and purification trains.

Clinical and commercial supply

Multiproduct manufacturing of proteins and antibodies in two separate trains

Stainless Steel and Single-Use bioreactors

2,000 L and 15,000 L capacity

Shanghai, China

Our site in Shanghai is part of the global biopharmaceuticals manufacturing network and was the first multinational commercial mammalian cell culture facility in China. cGMP compliant, it is flexible and fully disposable, offering scale-out and scale-up capabilities.

Clinical and commercial supply

Aseptic Filling in vials for liquids

Upstream and downstream process optimization

Single-use bioreactors – up to 3 x 2,000 L